ConductScience.org, home

Paper772446

Nalidixic acid and bacterial chromosome replication.

Crumplin GC and 1 other. Nature, 1976. Cited by 65 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Nalidixic acid and bacterial chromosome replication. Papers, record 772446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/772446

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nalidixic acid and bacterial chromosome replication.
PubMed
Journal
Nature
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.01
iCite
Revised in PubMed
2019-06-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crumplin GCG C
2Smith JTJ T

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chromosomes, BacterialMajor topic
DNA ReplicationMajor topic
DNA, BacterialMajor topic
Nalidixic AcidMajor topic
Escherichia coli
Molecular Weight
Mutation
Time Factors

Source PubMed

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
39,598,446Antibacterial Mechanisms and Clinical Impact of Sitafloxacin.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39598446PubMed
34,199,768Mutations in bdcA and valS Correlate with Quinolone Resistance in Wastewater Escherichia coli.Int J Mol Sci2021https://conductscience.org/library/papers/34199768PubMed
26,545,354Synthesis, characterization, DNA interactions, DNA cleavage, radical scavenging activity, antibacterial, anti-proliferative and docking studies of new transition metal complexes.J Fluoresc2016https://conductscience.org/library/papers/26545354PubMed
10,747,156Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing.J Clin Microbiol2000https://conductscience.org/library/papers/10747156PubMed
10,553,697The future of the quinolones.Drugs1999https://conductscience.org/library/papers/10553697PubMed
7,689,439The future of the quinolones.Drugs1993https://conductscience.org/library/papers/7689439PubMed
6,347,618Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.Drugs1983https://conductscience.org/library/papers/6347618PubMed
6,302,690recF-dependent induction of recA synthesis by coumermycin, a specific inhibitor of the B subunit of DNA gyrase.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6302690PubMed
6,271,730New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.J Bacteriol1981https://conductscience.org/library/papers/6271730PubMed
3,549,037Antibacterial therapy in patients with malignancies.Cancer Metastasis Rev1987https://conductscience.org/library/papers/3549037PubMed
3,438,148In vitro activity and mode of action of fluoroquinolones.Pharm Weekbl Sci1987https://conductscience.org/library/papers/3438148PubMed
3,053,126Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.Drugs1988https://conductscience.org/library/papers/3053126PubMed
2,971,603Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.Genitourin Med1988https://conductscience.org/library/papers/2971603PubMed
2,665,642Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2665642PubMed
2,420,724[Mechanism of action of quinolones].Infection1986https://conductscience.org/library/papers/2420724PubMed
1,963,289Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1963289PubMed
1,708,224Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1708224PubMed
375,000Mechanisms of recombination by the RecBC and the RecF pathways following conjugation in Escherichia coli K12.Mol Gen Genet1979https://conductscience.org/library/papers/375000PubMed
326,773R-plasmid transfer and its response to nalidixic acid.J Bacteriol1977https://conductscience.org/library/papers/326773PubMed
321,429Temporal sequence of events during the initiation process in Escherichia coli deoxyribonucleic acid replication: roles of the dnaA and dnaC gene products and ribonucleic acid polymerase.J Bacteriol1977https://conductscience.org/library/papers/321429PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/772446

GET https://conductscience.org/api/papers/v1/772446/cited_by?page=2